Ontology highlight
ABSTRACT:
SUBMITTER: Chu Y
PROVIDER: S-EPMC6555680 | biostudies-literature | 2019 Jun
REPOSITORIES: biostudies-literature
Chu Yaya Y Gardenswartz Aliza A Termuhlen Amanda M AM Cairo Mitchell S MS
British journal of haematology 20190106 6
Patients with relapsed, refractory or advanced stage B non-Hodgkin lymphoma (NHL) continue to have a dismal prognosis. This review summarises current and novel cellular and immunotherapy for these high-risk populations, including haematopoietic stem cell transplant, bispecific antibodies, viral-derived cytotoxic T cells, chimeric antigen receptor (CAR) T cells, and natural killer (NK) cell therapy, as discussed at the 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgk ...[more]